Magnolia Medical Technologies Revenue and Competitors
Estimated Revenue & Valuation
- Magnolia Medical Technologies's estimated annual revenue is currently $33.6M per year.
- Magnolia Medical Technologies's estimated revenue per employee is $251,000
- Magnolia Medical Technologies's total funding is $117.3M.
Employee Data
- Magnolia Medical Technologies has 134 Employees.
- Magnolia Medical Technologies grew their employee count by 10% last year.
Magnolia Medical Technologies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $44.9M | 143 | -30% | $211.3M | N/A |
#2 | $54M | 172 | 11% | $35.5M | N/A |
#3 | $5.3M | 21 | 0% | N/A | N/A |
#4 | $18.3M | 73 | N/A | N/A | N/A |
#5 | $7.8M | 31 | -16% | N/A | N/A |
#6 | $58M | 231 | 13% | N/A | N/A |
#7 | $6M | 23 | 10% | N/A | N/A |
#8 | $8M | 32 | 10% | N/A | N/A |
#9 | $198.5M | 791 | 3% | N/A | N/A |
#10 | $6.3M | 50 | 25% | $27.5M | N/A |
What Is Magnolia Medical Technologies?
Magnolia Medical Technologies develops innovative medical products that achieve predictable, high-quality outcomes. The company's first product SteriPath is the only clinically proven blood culture collection solution that maintains consistent, sustainable contamination rates as low as 0.2%. By enabling providers to consistently execute best practices, SteriPath virtually eliminates false positives--mitigating previously unavoidable clinical and financial risks, reducing unnecessary treatment, and ensuring optimal patient outcomes.
keywords:N/A
$117.3M
Total Funding
134
Number of Employees
$33.6M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Magnolia Medical Technologies's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director Strategic Accounts | |
2 | Senior Manager, Program Management | |
3 | Business Director | |
4 | Principal Mechanical Engineer | |
5 | Territory Manager | |
6 | ERP Analyst | |
7 | Business Director | |
8 | Business Director | |
9 | Business Director | |
10 | Senior Executive Assistant |
Magnolia Medical Technologies News
SEATTLE, April 6, 2022 /PRNewswire/ -- Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device...
SEATTLE, July 29, 2021 /PRNewswire/ -- Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination1 for sepsis testing, announces the commercial availability of its new Steripath® Micro Initial Specim ...
SEATTLE, June 9, 2021 /PRNewswire/ -- Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination,1 announced today continued clinical efficacy data supporting multiple, peer-reviewed clinical studies ...
SEATTLE, April 14, 2021 /PRNewswire/ -- Magnolia Medical Technologies, Inc. recently launched a new multi-media advertising campaign to promote the benefits of the Steripath® Initial Specimen Diversion Device® (ISDD®) platform. Built around the theme "Diverted", the campaign underscores the c ...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $36.2M | 134 | 8% | N/A |
#2 | $24.1M | 134 | 23% | N/A |
#3 | $19.4M | 134 | 9% | N/A |
#4 | $36.2M | 134 | 0% | N/A |
#5 | $36.5M | 135 | 11% | N/A |